Consortium's induced stem cell line offers hope for bipolar disorder
A stem cell line created by the Taubman Institute's Consortium for Stem Cell Therapies may help in finding new treatments for people with bipolar disorder.
As featured on the health news service Advanceweb.com, the consortium scientists used skill cells from patients with bipolar disorder to create induced pluripotent stem cells (iPSC) which then can be manipulated to develop into different types of cells, including brain cells. In turn, that will help scientists study various attributes of the neurons of people with the disorder.
The bipolar line is one of several iPSC and embryonic lines already created by the consortium, which was founded in 2009 with support from the A. Alfred Taubman Medical Research Institute.
Taubman Emerging Scholars Program
Request for applications
Applications are being accepted for the Taubman Institute Emerging Scholars Program.
The applicant must be a junior member of the faculty at the University of Michigan; generally, that means holding an assistant professor title. The applicant must have either an M.D. or an M.D./Ph.D. It is required that candidates both conduct basic research and treat patients.
Applicants should submit a two-to-three page research proposal, as well as a current CV. Priority will be given to proposals involving translational research. Please submit material to This e-mail address is being protected from spambots. You need JavaScript enabled to view it. . The deadline is May 7, 2012.
Young Friends host festive NYC fundraiser
Reception introduced scholar candidate Dr. Parag Patil
About 125 supporters of cutting-edge medical research mixed socializing and science May 9 at a cocktail party in Manhattan hosted by the Young Friends of the Taubman Institute's New York City chapter.
The event introduced Dr. Parag Patil, a University of Michigan physician-researcher and a prospective Young Friends Emerging Scholar. Here's a clip from Dr. Patil's appearance on the TV program "The Doctors," where he demonstrates how deep-brain stimulation has helped a patient with Parkinson's disease.
Emerging Scholars are early-career clinician-scientists who show great promise in research aimed at new cures or treatments; through the Taubman Institute, donors support them with three-year grants while their labs earn the credentials to win broader funding support.
The Young Friends event, which raised a significant contribution toward the Emerging Scholars program, was held at the ABC Carpet & Home showrooms at 888 Broadway, Attendees enjoyed cocktails, appetizers, a silent auction and a presentation by Dr. Patil. The silent auction included jewelry, fashion items, a Botox consultation and treatment, Morgan Hotel Group rooms and the opportunity to bid on a meeting and photo with former President William Jefferson Clinton.
Taubman Research
Dr. Max Wicha: Some treatments actually increase cancer stem cells
Avastin and Sutent have been found to increase the growth of breast cancer stem cells in mice, according to Taubman Scholar Dr. Max Wicha, director of the U-M Comprehensive Cancer Center.



